2024 Q1 Form 10-Q Financial Statement

#000143774924016895 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $1.338M $1.322M
YoY Change 1.23% -27.39%
Cost Of Revenue $706.2K $681.0K
YoY Change 3.7% -45.66%
Gross Profit $632.2K $641.1K
YoY Change -1.38% 12.96%
Gross Profit Margin 47.24% 48.49%
Selling, General & Admin $431.1K $741.8K
YoY Change -41.88% 7.11%
% of Gross Profit 68.2% 115.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.880K $4.220K
YoY Change -8.06% -87.25%
% of Gross Profit 0.61% 0.66%
Operating Expenses $431.1K $741.8K
YoY Change -41.88% 7.11%
Operating Profit $201.1K -$100.7K
YoY Change -299.6% -19.41%
Interest Expense $91.23K
YoY Change
% of Operating Profit 45.37%
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income $292.3K -$100.7K
YoY Change -390.17% 223.35%
Income Tax $105.0K $0.00
% Of Pretax Income 35.92%
Net Earnings $187.3K -$100.7K
YoY Change -285.93% 223.35%
Net Earnings / Revenue 13.99% -7.62%
Basic Earnings Per Share $0.19 -$0.10
Diluted Earnings Per Share $0.18 -$0.10
COMMON SHARES
Basic Shares Outstanding 985.9K 976.3K
Diluted Shares Outstanding 1.013M 995.6K

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.666M $6.149M
YoY Change 57.2% 98.72%
Cash & Equivalents $6.202M $6.149M
Short-Term Investments $3.464M
Other Short-Term Assets $660.0K $215.1K
YoY Change 206.88% 2.08%
Inventory $5.421K $2.772K
Prepaid Expenses $660.0K $215.1K
Receivables $238.6K $202.2K
Other Receivables $44.90K $279.9K
Total Short-Term Assets $10.62M $6.849M
YoY Change 54.99% 49.84%
LONG-TERM ASSETS
Property, Plant & Equipment $47.73K $38.65K
YoY Change 23.51% -84.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $47.73K $38.65K
YoY Change 23.51% -97.19%
TOTAL ASSETS
Total Short-Term Assets $10.62M $6.849M
Total Long-Term Assets $47.73K $38.65K
Total Assets $10.66M $6.888M
YoY Change 54.82% 15.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $442.2K $381.2K
YoY Change 16.0% -23.18%
Accrued Expenses $1.433M $594.4K
YoY Change 141.0% 49.4%
Deferred Revenue $256.6K $204.6K
YoY Change 25.38% 13.13%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.131M $1.180M
YoY Change 80.58% 4.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.131M $1.180M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $2.131M $1.180M
YoY Change 80.58% -21.35%
SHAREHOLDERS EQUITY
Retained Earnings -$11.43M -$14.16M
YoY Change -19.31% -7.67%
Common Stock $19.96M $19.87M
YoY Change 0.45% 0.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.532M $5.707M
YoY Change
Total Liabilities & Shareholders Equity $10.66M $6.888M
YoY Change 54.82% 15.86%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $187.3K -$100.7K
YoY Change -285.93% 223.35%
Depreciation, Depletion And Amortization $3.880K $4.220K
YoY Change -8.06% -87.25%
Cash From Operating Activities $193.5K $171.8K
YoY Change 12.65% -74.06%
INVESTING ACTIVITIES
Capital Expenditures $2.170K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$920.7K
YoY Change
Cash From Investing Activities -$922.9K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities $193.5K $171.8K
Cash From Investing Activities -$922.9K $0.00
Cash From Financing Activities $0.00
Net Change In Cash -$729.4K $171.8K
YoY Change -524.63% -73.47%
FREE CASH FLOW
Cash From Operating Activities $193.5K $171.8K
Capital Expenditures $2.170K $0.00
Free Cash Flow $191.3K $171.8K
YoY Change 11.39% -74.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
985888
CY2024Q1 us-gaap Gross Profit
GrossProfit
632195 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
431133 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
201062 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-100730 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5707295 usd
CY2024Q1 skas Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
25420 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
8531677 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
187290 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-100730 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3879 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4216 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
25420 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
25500 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-55933 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-42316 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4279 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10779 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-85598 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-139844 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3126 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-262963 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
52667 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
99493 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2824 usd
CY2024Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
6207 usd
CY2023Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
272498 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
193497 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
171768 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-729372 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6931709 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5977157 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6202337 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
187290 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
187290 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
985888
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001128281
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 skas Interim Agreement Renewal Period
InterimAgreementRenewalPeriod
P6M
CY2023Q3 skas Interim Agreement Initial Term
InterimAgreementInitialTerm
P6M
CY2018Q1 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.03
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3333334
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
985888
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
29577 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19902505 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11613115 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
8318967 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10610638 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
741781 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-100730 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
91228 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
292290 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-100730 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
105000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
187290 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-100730 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
985888
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
976330
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1013231
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
995604
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5782525 usd
CY2023Q1 skas Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
25500 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
8318967 usd
CY2024Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
920699 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2170 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-922869 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
171768 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6148925 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
25313 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">NOTE 1 - <span style="text-decoration: underline; ">Basis of Presentation</span></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The accompanying unaudited condensed consolidated financial statements of Saker Aviation Services, Inc. (the “Company”) and its subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial statements and in accordance with the instructions to Form 10-Q. Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements and should be read in conjunction with the financial statements and related footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The condensed consolidated balance sheet as of March 31, 2024 and the condensed consolidated statements of operations and cash flows for the three months ended March 31, 2024 and 2023 have been prepared by the Company without audit. In the opinion of the Company’s management, all necessary adjustments (consisting of normal recurring accruals) have been included to make the Company’s financial position as of March 31, 2024 and its results of operations, stockholders’ equity, and cash flows for the three months ended March 31, 2024 not misleading. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for any full year or any other interim period.</p>
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6202337 usd
CY2024Q1 skas Working Capital
WorkingCapital
8483946 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1338367 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
187290 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
187290 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
193497 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-922869 usd
CY2015 skas Environmental Remediation Agreed Percentage Of Reduction In Tenant Operated Tourist Flights
EnvironmentalRemediationAgreedPercentageOfReductionInTenantOperatedTouristFlights
0.20 pure
CY2015 skas Environmental Remediation Agreed Percentage Of Reduction In Tenant Operated Tourist Flights By Year One
EnvironmentalRemediationAgreedPercentageOfReductionInTenantOperatedTouristFlightsByYearOne
0.40 pure
CY2015 skas Environmental Remediation Agreed Percentage Of Reduction In Tenant Operated Tourist Flights By Year Two
EnvironmentalRemediationAgreedPercentageOfReductionInTenantOperatedTouristFlightsByYearTwo
0.50 pure
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
246000 usd
CY2023Q3 skas Amount Of Gross Receipts During Initial Term
AmountOfGrossReceiptsDuringInitialTerm
1036811 usd
CY2023Q3 skas Percentage Of Gross Receipts During Initial Term
PercentageOfGrossReceiptsDuringInitialTerm
0.30 pure
CY2023Q3 skas Amount Of Gross Receipts During Both Renewal Periods
AmountOfGrossReceiptsDuringBothRenewalPeriods
518406 usd
CY2023Q3 skas Percentage Amount Of Gross Receipts During Both Renewal Periods
PercentageAmountOfGrossReceiptsDuringBothRenewalPeriods
0.30 pure
CY2024Q1 skas Concession Fees
ConcessionFees
425000 usd
CY2023Q1 skas Concession Fees
ConcessionFees
343000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-100730 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
985888
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
976330
CY2024Q1 skas Incremental Common Shares Attributable To Options And Warrants
IncrementalCommonSharesAttributableToOptionsAndWarrants
27343
CY2023Q1 skas Incremental Common Shares Attributable To Options And Warrants
IncrementalCommonSharesAttributableToOptionsAndWarrants
19274
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1013231
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
995604
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
25420 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
25500 usd
CY2024Q1 skas Shares Based Compensation Stock Options Unamortized Fair Value
SharesBasedCompensationStockOptionsUnamortizedFairValue
76260 usd

Files In Submission

Name View Source Status
0001437749-24-016895-index-headers.html Edgar Link pending
0001437749-24-016895-index.html Edgar Link pending
0001437749-24-016895.txt Edgar Link pending
0001437749-24-016895-xbrl.zip Edgar Link pending
ex_669857.htm Edgar Link pending
ex_669858.htm Edgar Link pending
ex_669859.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skas-20240331.xsd Edgar Link pending
skas20240331_10q.htm Edgar Link pending
skas20240331_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
skas-20240331_pre.xml Edgar Link unprocessable
skas-20240331_cal.xml Edgar Link unprocessable
skas-20240331_def.xml Edgar Link unprocessable
skas-20240331_lab.xml Edgar Link unprocessable